Antimicrobial resistance (AMR) refers to changes in infectious organisms (viruses, bacteria, fungi and parasites) so that they can no longer be controlled or treated effectively by standard drugs such as antibiotics, antivirals and antifungals.
AMR is an increasingly serious threat to public health and NCCID works with partners across the country to provide evidence and resources on AMR surveillance and antimicrobial use (AMU).
Antibiotic Awareness Week
Antibiotic resistance is an issue health practitioners around the world face daily. Numerous Canadian health-related organizations have partnered in an effort to promote the prudent use of antibiotics and fight the threat of antibiotic-resistant bacteria. It is hoped these efforts will help improve public health in Canada by offering practical tools that focus on the threat of antibiotic resistance.
NCCID has assembled a glossary of terms related to regulatory processes for ensuring the safety and efficacy of drug therapies, including new drugs and new therapeutic applications for existing drugs. The aim is to increase understanding of these terms and transparency on related policies that protect Canadians.
Antimicrobial resistance (AMR) is a recognized global public health threat. Integrated, One Health based surveillance of AMR and antimicrobial use…
This webinar provides an overview to public health personnel on AMR surveillance in Canada and opportunities to use surveillance data to support public health planning, decision-making and response.
This February 2019 presentation explored ethical considerations of appropriate antibiotic prescribing of public health, primary care and specialist physicians, where there may be perceived tension between duty to individual patients and duty to avoid overuse of antimicrobials.
On January 22nd and 23rd, 2019, the National Collaborating Centre for Infectious Diseases (NCCID) and the Public Health Agency of…
REGISTRATION CLOSED A copy of this webinar is available upon request. Please contact NCCID Project Manager Harpa Isfeld-Kiely to learn more,…
Viral Prescription Pads
Provides information about symptomatic relief for infections and indicates when patients should consider a return visit. To be used with patients (adults and children) who have a suspected viral infection.
Download below or order free copies of prescription pads, here.
Surveillance of Antimicrobial Resistance and Antimicrobial Utilization in Canada
This report summarizes the results of a 2012–2013 project sponsored by the National Collaborating Centre for Infectious Diseases. The task set forth was both to assess the current status of surveillance of antibiotic or antimicrobial use (AMU) and antimicrobial resistance (AMR) in Canada, and to provide recommendations to advance Canadian surveillance. This project had three main components:
- A systematic literature search was performed to identify, describe and evaluate Canadian and international AMR and AMU surveillance programs, with analysis of their attributes. A structured evaluation method was applied to exemplar Canadian and international systems, and a more detailed analysis review of two models of surveillance (Denmark’s DANMAP program and the European Centre for Disease Control and Prevention’s EARS-Net and ESAC-Net programs) was performed to identify their relevance, strengths and weaknesses in potential application to a Canadian context.
- A semi-structured interview protocol surveyed Canadian experts from key stakeholder groups (including but not limited to public health and infectious diseases physicians, physician and PhD microbiologists, antimicrobial pharmacists, veterinarians, and representatives of the food animal industry) to ensure a full understanding of current functioning Canadian AMR and AMU surveillance in all sectors, to identify perceived strengths, and weaknesses, and to identify perceived needs.
- A review of previous Canadian antimicrobial resistance and surveillance consensus meetings, reports and recommendations to inform the development of an actionable set of recommendations.
Putting the Pieces Together: A National Action Plan on Antimicrobial Stewardship
This document provides a roadmap for improving antimicrobial stewardship (AMS) in Canada and lays out a series of 10 areas for a national Action Plan on antimicrobial stewardship in which governments, healthcare organizations and professionals, civil society groups and the public can collaborate to preserve the effectiveness of antimicrobial drugs such as antibiotics. It is built on the work of 50 experts, key influencers and stakeholders in the field of antimicrobial stewardship (AMS) and antimicrobial resistance (AMR) who met at a national roundtable in June 2016.
The Antimicrobial Stewardship Directory provides information about the commitments and activities of the participants at the 2016 Canadian Round Table for Antimicrobial Stewardship. The activities correspond with the commitments of each member agency as outlined by the Putting the Pieces: A National Action Plan for Antimicrobial Stewardship.
- Glossary of Terms: Antimicrobial Resistance
- The Role of Human Health and Animal Health in Antimicrobial Resistance
- A Provincial Antimicrobial Stewardship Program: Successes and Challenges in Alberta
- Community-Acquired Antimicrobial Resistance: Consultation Notes
- Strategies to Control Community-Associated Antimicrobial Resistance Among Enteric Bacteria and MRSA in Canada: A comprehensive review
- Surveillance of Antimicrobial Resistance and Antimicrobial Utilization in Canada
- The W-5 of NDM-1: The Pinnacle of Antimicrobial Resistance
- Antimicrobial Use and Resistance in Pigs and Chickens: A review of the science, policy, and control practices from farm to slaughter
- A Review of Alternative Practices to Antimicrobial Use for Disease Control in the Commercial Feedlot
Vaccine hesitancy and First Nations, Inuit and Métis populations – Potential implications during COVID-19
This webinar discusses some of the specific challenges for vaccine uptake amongst First Nations, Inuit and Métis populations, including their negative historic and contemporary experiences with mainstream healthcare systems, health care professionals, and vaccine providers in Canada.
To support public health knowledge translation during the current outbreak of 2019 Novel Coronavirus, NCCID is releasing a Q+A podcast…
Recommendations of the National Advisory Committee on Immunization (NACI) on the use of the Moderna COVID-19 vaccine
This webinar is to inform health care and vaccine providers on the NACI recommendations on the use of the Moderna COVID-19 vaccine.